SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending due to its focus on providing high-throughput, compliant infrastructure for institutional finance, particularly its recent integration of a Stripe-backed fiat on/off-ramp. The community is discussing how Keeta complements existing blockchains rather than competing, highlighting its potential for cross-chain routing and institutional settlement. With verified stress tests exceeding 11 million transactions per second and a compliance-first approach, Keeta is positioned as a serious contender for regulated entities looking to navigate the on-chain landscape.

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.

Edgewise Therapeutics Inc

Edgewise Therapeutics is trending amid positive analyst sentiment and anticipation for upcoming clinical trial data, particularly for its lead drug in Becker muscular dystrophy. Community members are discussing potential catalysts and entry points, while analysts highlight the company's potential to address unmet needs in muscle disease. Positive phase 3 data from competitors in the same space may act as a catalyst.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to renewed social media speculation surrounding a prior AI server deal and its low float, with traders discussing potential short squeeze opportunities and comparing it to other recent low-float runners. The community is closely watching key breakout levels, anticipating a significant price surge if certain resistance points are cleared. Bullish sentiment is fueled by the stock's momentum and potential for a parabolic run.

Folks Finance is a crosschain decentralized finance (DeFi) protocol that enables users to supply, borrow, and manage digital assets across multiple blockchains from a single platform. By using interoperability technology like Chainlink CCIP, Circle CCTP, and Wormhole messaging, the protocol eliminates the need for wrapping, bridging, or splitting liquidity, allowing users to access unified pools and collateralize assets natively across ecosystems. Its design focuses on efficiency, security, and accessibility for both retail users and institutions.

FOLKS

Folks Finance ($FOLKS) is trending as the community discusses the recent token airdrop and its potential value, with some users planning to sell their tokens as they unlock. The cross-chain expansion and new exchange listings are also being noted as potential drivers for adoption. Sentiment is mixed, with some expressing excitement about potential gains and others questioning the token's long-term value.

Chill House

Chill House is trending as traders discuss potential setups for another run, with some highlighting it as an easy swing play. However, increased volatility is noted by some, while others are glad they sold. The crypto is also being mentioned alongside other meme tokens like Doge and Shiba.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy`s Co

Wendy's ($WEN) is trending as buyout rumors circulate, driving significant call option activity. Community members are weighing the potential for a short squeeze given the high short interest, while others discuss the company's valuation, dividend, and turnaround prospects. Some investors express optimism about the company's new menu items and international expansion.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token is trending amid community excitement and claims of a prophecy being fulfilled, with many believing it's the next big meme coin on the Ethereum network. Chatter highlights the strong community, compelling narrative, and potential for significant growth, drawing comparisons to previous meme coin successes like Pepe and Doge. The community emphasizes 'studying the lore' and its connection to Ethereum's on-chain activity, suggesting a deeper significance beyond typical meme coin hype.

Running the Shiba realm on the Base Chain like a boss, one bark at a time !

Shiba Fantom

Shiba Fantom ($SHIBA) is gaining attention, with community members highlighting its potential for another run, driven by its presence on the Fantom network. Discussions also involve potential breakouts and comparisons to other meme coins like $DOGE and $PEPE. The community emphasizes its features like fast, easy, and cheap transactions.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

SCLX is trending as investors discuss the company's recent loan agreement and its implications for related holdings like DVLT. Community talking points revolve around potential dilution, the company's financial stability, and the strategic rationale behind these financial maneuvers. Overall sentiment appears mixed, with some expressing concern and others remaining optimistic about the long-term prospects.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors await the 48-week data release and potential FDA feedback, with discussions focusing on trial design and data interpretation. Community members are debating the implications of past data disclosures and the company's future prospects, with some expressing concerns about trial outcomes. The new CEO's background and potential for strategic partnerships are also key talking points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
